Mengxing Xue

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Genome Wide Identification

Tyrosine Kinase

Acute Lymphoblastic Leukemia

Top Venues

Clinical case reports

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Li Huo, Jundan Xie, Qian Wang, Hongjie Shen, Zixuan Ding, Lijun Wen, Zhao Zeng, Yi Xu, Changgeng Ruan, Su-Ning Chen, Mengxing Xue
Insights from a rare myeloproliferative neoplasm with coexisting BCR-ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib. Clinical case reports 11 (1) (2023)
Li Huo, Jundan Xie, Qian Wang, Hongjie Shen, Zixuan Ding, Lijun Wen, Zhao Zeng, Yi Xu, Changgeng Ruan, Su-Ning Chen, Mengxing Xue
Insights from a rare myeloproliferative neoplasm with coexisting BCR-ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib. Clinical case reports 11 (1) (2023)
Yilin Chen, Na Xu, Yunfan Yang, Zhenfang Liu, Mengxing Xue, Li Meng, Qun He, Chunyan Chen, Qingshu Zeng, Huanling Zhu, Xin Du, Jing Zou, Wenjun He, Jingming Guo, Su-Ning Chen, Guolin Yuan, Hui Wu, Mei Hong, Fanjun Cheng, Bingcheng Liu, Yanli Zhang, Wei-Ming Li
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia. Cancer medicine (2023)